Discover what sets IXICO PLC (LSE:IXI, OTC:PHYOF) apart from competitors. CEO Bram Goorden discusses how artificial intelligence powers IXICO’s platform, enabling faster, more accurate neuro image analysis. He shares the company’s innovation roadmap and how it will help expand into new applications and revenue streams.
Click the link in the video, or visit the IXICO profile to view the full interview.
#Neuroscience #CNS #Biomarkers #ClinicalResearch #LifeSciences #IXICO #Neuroimaging #AlzheimersResearch #ParkinsonsDisease #AIDrivenHealthcare #Biomarkers #ClinicalResearch #HealthcareInnovation #UKStocks #BramGoorden #ProactiveInvestors #MedicalAI #LifeSciences #PostMarketingSurveillance #AI #AIinHealthcare #Alzheimers #Parkinsons #BiotechInnovation